A Comprehensive Workflow for a Large Panel of Drugs of Abuse in Human Whole Blood by LC/MS/MS

Aplikace | 2020 | Agilent TechnologiesInstrumentace
Příprava vzorků, Spotřební materiál, LC/MS, LC/MS/MS, LC/QQQ
Zaměření
Forenzní analýza a toxikologie
Výrobce
Agilent Technologies
Přejít do knihovnyZobrazit PDF
PDF verze ke stažení a čtení
 

Podobná PDF

Screening, Identification, and Quantitation of 102 Drugs in Human Whole Blood by LC/Q-TOF and LC‑QQQ
Screening, Identification, and Quantitation of 102 Drugs in Human Whole Blood by LC/Q-TOF and LC‑QQQ
2020|Agilent Technologies|Aplikace
Quantitative Determination of Drugs of Abuse in Human Whole Blood by LC/MS/MS Using Agilent Captiva EMR—Lipid Cleanup
Quantitative Determination of Drugs of Abuse in Human Whole Blood by LC/MS/MS Using Agilent Captiva EMR—Lipid Cleanup
2018|Agilent Technologies|Aplikace
Screening, Identification, and Quantitation of Drugs of Abuse in Human Whole Blood by LC/Q-TOF and LC/MS/MS
Screening, Identification, and Quantitation of Drugs of Abuse in Human Whole Blood by LC/Q-TOF and LC/MS/MS
2022|Agilent Technologies|Postery
Quantitative Determination of Drugs of Abuse in Human Plasma and Serum by LC/MS/MS Using Agilent Captiva EMR—Lipid Cleanup
Quantitative Determination of Drugs of Abuse in Human Plasma and Serum by LC/MS/MS Using Agilent Captiva EMR—Lipid Cleanup
2018|Agilent Technologies|Aplikace